Key Metrics
CiteScore 

1.2
Impact Factor 

< 5
SJR 

Q4Biophysics

SNIP 

0.31
Recommended pre-submission checks
Powered by 

Topics Covered on Current Pharmaceutical Analysis
Current Pharmaceutical Analysis Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2005 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Pharmaceutical Analysis ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Current Pharmaceutical Analysis
Astragaloside IV Alleviates Peritoneal Dialysis-Related Peritoneal Fibrosis by Regulating HIF-1α-Mediated Autophagy
- 1 Oct 2026
- Current Pharmaceutical Analysis
Novel dichloroacetamide derivatives: Synthesis, cytotoxicity evaluation, molecular docking study, MD simulations, and ADME study
- 1 Oct 2026
- Current Pharmaceutical Analysis
A novel stability indicating LC method for simultaneous determination of Vildagliptin and Pioglitazone hydrochloride in API and marketed formulations
- 1 Oct 2026
- Current Pharmaceutical Analysis
Network pharmacology and molecular docking reveal the active compounds and key targets of JiaWei SiNi San in hepatocellular carcinoma
- 1 Oct 2026
- Current Pharmaceutical Analysis
Refining sedation strategies in elderly patients: A critical analysis of esketamine and propofol combination in gastrointestinal endoscopy
- 1 Oct 2026
- Current Pharmaceutical Analysis
Applications of QSPR polynomial and empirical models for predicting physicochemical properties of pharmaceutically important compounds
- 1 Oct 2026
- Current Pharmaceutical Analysis
Astragaloside IV Alleviates Peritoneal Dialysis-Related Peritoneal Fibrosis by Regulating HIF-1α-Mediated Autophagy
- 1 Oct 2026
- Current Pharmaceutical Analysis
Novel dichloroacetamide derivatives: Synthesis, cytotoxicity evaluation, molecular docking study, MD simulations, and ADME study
- 1 Oct 2026
- Current Pharmaceutical Analysis
A novel stability indicating LC method for simultaneous determination of Vildagliptin and Pioglitazone hydrochloride in API and marketed formulations
- 1 Oct 2026
- Current Pharmaceutical Analysis
Network pharmacology and molecular docking reveal the active compounds and key targets of JiaWei SiNi San in hepatocellular carcinoma
- 1 Oct 2026
- Current Pharmaceutical Analysis
Refining sedation strategies in elderly patients: A critical analysis of esketamine and propofol combination in gastrointestinal endoscopy
- 1 Oct 2026
- Current Pharmaceutical Analysis
Applications of QSPR polynomial and empirical models for predicting physicochemical properties of pharmaceutically important compounds
- 1 Oct 2026
- Current Pharmaceutical Analysis
FAQs on Current Pharmaceutical Analysis
How long has Current Pharmaceutical Analysis been actively publishing? 
What is the publishing frequency of Current Pharmaceutical Analysis? 
How many articles did Current Pharmaceutical Analysis publish last year? 
What is the eISSN & pISSN for Current Pharmaceutical Analysis? 
What is Citescore for Current Pharmaceutical Analysis? 
What is SNIP score for Current Pharmaceutical Analysis? 
What is the SJR for Current Pharmaceutical Analysis? 
Who is the publisher of Current Pharmaceutical Analysis? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary